Comparing FDA Approved Bipolar Depression Medications

Depression in bipolar disorder is considered the most common mood phase and also a major clinical challenge.  This is known to cause impairment from being symptomatic with syndromal or subsyndromal symptoms. For this reason, we should have the knowledge of available FDA-approved medications for bipolar depression.

Psychiatry Education Forum Academy’s most recent video discussion will compare the following five FDA approved medications for bipolar depression:

  1. Olanzapine + Fluoxetine
  2. Quetiapine
  3. Lurasidone
  4. Cariprazine
  5. Lamotrigine
  6. Lumateperone

Lumateperone is the most recently FDA-approved medication for bipolar depression (read detailed post here).

Comparing FDA Approved Medications for Bipolar Depression

This 30 minutes video discussion will be summarized in the following 10 clinically relevant sections:

  1. FDA Approved Indication: Bipolar Depression.
  2. FDA Approved Indication: Bipolar Disorder Phases (Depression, Mania and Mixed)
  3. Pediatric Bipolar Disorder FDA Indications.
  4. Non-Bipolar Psychiatric Indications.
  5. Bipolar Disorder Guidelines: CANMAT & ISBD (2018)
  6. Dosing & Need for Titration.
  7. Renal and Hepatic Impairment.
  8. CardiaC Risk: QTc & Torsdaes.
  9. Metabolic Side Effects
  10. Drug Interactions

HERE IS ONE OF THE SLIDE FROM THIS PRESENTATION:

INTERESTED IN LEARNING MORE?

JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP

This is a closed membership for medical professionals only.

  • 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
  • Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections. 
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Conference Discounts: Academy members get discounted access at our conferences. 
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
 

SUBSCRIBE TO OUR EMAIL NEWSLETTER:

Related Articles

Responses

Your email address will not be published. Required fields are marked *